Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Psychopharmacology (Berl). 2015 Jan 11;232(12):2181–2189. doi: 10.1007/s00213-014-3848-z

Fig. 5.

Fig. 5

Effects of early postnatal treatment with the VPAC2 receptor agonist Ro 25-1553 on memory formation, retention and extinction in the fear conditioning test. (a) Acquisition. BL; baseline, T; tone. (b) Contextual fear test. (c) Tone-cued fear test. **P < 0.01 compared with the baseline. (d) Cued fear extinction. BL; baseline. **P < 0.01 compared with the baseline in the PBS-treated group. †P < 0.05 compared with the baseline in the Ro 25-1553 (P1-7)-treated group. §P < 0.05 compared with the baseline in the Ro 25-1553 (P1-14)-treated group. The results are expressed as the mean ± SEM of 8 mice/group.